Excessive sympathetic activation in heart failure with chronic renal failure: Role of chemoreflex activation

Journal of Hypertension

Volumn 27, Issue 9, 2009, Pages 1849-1854

  Despas, Fabien ^a,b,d   Detis, Nicolas ^c   Dumonteil, Nicolas ^c   Labrunee, Marc ^a,b   Bellon, Brigitte ^d   Franchitto, Nicolas ^a,b   Galinier, Michel ^a,b,c   Senard, Jean Michel ^a,b   Pathak, Atul ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c Toulouse Faculty of Medicine ^*  (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Chemoreflex; Chronic heart failure; Chronic renal failure; Microneurography; Sympathetic nerve activity

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY MASS; CHEMORECEPTOR REFLEX; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMAN; MALE; MUSCLE BLOOD FLOW; NEUROGRAPHY; OXYGEN BREATHING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STATISTICAL SIGNIFICANCE; SYMPATHETIC NERVE; SYMPATHETIC TONE;

EID: 73249134149     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32832e8d0f     Document Type: Article

References (22)

1. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 2001; 22: 1136-1143. (Pubitemid 32666655)
2. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner Pl. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615-621.
3. Cohn JN. Sympathetic nervous system in heart failure. Circulation 2002; 106: 2417-2418. (Pubitemid 35278794)
4. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, FouadTarazi F, et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912-1918. (Pubitemid 23006966)
5. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9 (12 Suppl): S16-S23.
6. Zoccali C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105: 1354-1359. (Pubitemid 34260428)
7. Neumann J, Ligtenberg G, Klein IH, Boer P, Oey PL, Koomans HA, et al. Sympathetic hyperactivity in hypertensive chronic kidney disease patients is reduced during standard treatment. Hypertension 2007; 49: 506-510. (Pubitemid 46263234)
8. Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6427 patients with heart failure and coronary artery disease. J Am Coll Cardiol 2004; 44: 1587-1592. (Pubitemid 39369790)
9. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109: 1004-1009. (Pubitemid 38282853)
10. Pathak A, Velez-Roa S, Xhaet O, Najem B, van de Borne P. Dosedependent effect of dobutamine on chemoreflex activity in healthy volunteers. Br J Clin Pharmacol 2006; 62: 272-279. (Pubitemid 44215526)
11. DiBona GF. Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 2000; 36: 1083-1088.
12. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971; 285: 877-883.
13. Lee LY, Pisarri TE. Afferent properties and reflex functions of bronchopulmonary C-fibers. Respir Physiol 2001; 125: 47-65.
14. Ciarka A, Cuylits N, Vachiery JL, Lamotte M, Degaute JP, Naeije R, et al. Increased peripheral chemoreceptors sensitivity and exercise ventilation in heart transplant recipients. Circulation 2006; 113: 252-257. (Pubitemid 43754382)
15. Sun SY, Wang W, Zucker IH, Schultz HD. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 1999; 86: 1264-1272. (Pubitemid 29172161)
16. van de Borne P, Oren R, Anderson EA, Mark AL, Somers VK. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. Circulation 1996; 94: 1325-1328. (Pubitemid 26307260)
17. Ponikowski P, Chua TP, Anker SD, Francis DP, Doehner W, Banasiak W, et al. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation 2001; 104: 544-549. (Pubitemid 32738123)
18. Hering D, Zdrojewski Z, Krol E, Kara T, Kucharska W, Somers VK, et al. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J Hypertens 2007; 25: 157-161. (Pubitemid 44885677)
19. Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG. Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens 2002; 20: 3-9. (Pubitemid 34913395)
20. Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 1997; 51: 722-727 (Pubitemid 27157956)
21. Narkiewicz K, Pesek CA, van de Borne PJH, Kato M, Somers VK. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 1999; 100: 262-267. (Pubitemid 29340132)
22. Frank H, Heusser K, Hoffken B, Huber P, Schmieder RE, Schobel HP. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients. Kidney Int 2004; 66: 832-840. (Pubitemid 38982028)